Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
PLoS One ; 11(1): e0146440, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26771387

RESUMO

Despite a plethora of literature has documented that osteoarthritis (OA) is veritably associated with oxidative stress-mediated chondrocyte death and matrix degradation, yet the possible involvement of synoviocyte abnormality as causative factor of OA has not been thoroughly investigated. For this reason, we conduct the current studies to insight into how synoviocytes could respond to an episode of folate-deprived (FD) condition. First, when HIG-82 synoviocytes were cultivated under FD condition, a time-dependent growth impediment was observed and the demise of these cells was demonstrated to be apoptotic in nature mediated through FD-evoked overproduction of reactive oxygen species (ROS) and drastically released of cytosolic calcium (Ca2+) concentrations. Next, we uncovered that FD-evoked ROS overproduction could only be strongly suppressed by either mitochondrial complex II inhibitors (TTFA and carboxin) or NADPH oxidase (NOX) inhibitors (AEBSF and apocynin), but not by mitochondrial complex I inhibitor (rotenone) and mitochondrial complex III inhibitor (antimycin A). Interestingly, this selective inhibition of FD-evoked ROS by mitochondrial complex II and NOX inhibitors was found to correlate excellently with the suppression of cytosolic Ca2+ release and reduced the magnitude of the apoptotic TUNEL-positive cells. Taken together, we present the first evidence here that FD-triggered ROS overproduction in synoviocytes is originated from mitochondrial complex II and NOX. Both elevated ROS in tandem with cytosolic Ca2+ overload serve as final arbitrators for apoptotic lethality of synoviocytes cultivated under FD condition. Thus, folate supplementation may be beneficial to patients with OA.


Assuntos
Cálcio/metabolismo , Complexo II de Transporte de Elétrons/metabolismo , Deficiência de Ácido Fólico/metabolismo , NADPH Oxidases/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Animais , Apoptose/efeitos dos fármacos , Carboxina/farmacologia , Linhagem Celular , Complexo II de Transporte de Elétrons/antagonistas & inibidores , Ácido Fólico/metabolismo , Células HeLa , Humanos , NADPH Oxidases/antagonistas & inibidores , Oxirredução/efeitos dos fármacos , Estresse Oxidativo/fisiologia , Coelhos , Rotenona/farmacologia , Sulfonas/farmacologia , Tenoiltrifluoracetona/farmacologia
2.
Microb Pathog ; 66: 36-9, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24361395

RESUMO

Two virulence factors produced by Vibrio cholerae, cholera toxin (CT) and toxin-corregulated pilus (TCP), are indispensable for cholera infection. ToxT is the central regulatory protein involved in activation of CT and TCP expression. We previously reported that lack of a respiration-linked sodium-translocating NADH-ubiquinone oxidoreductase (Na(+)-NQR) significantly increases toxT transcription. In this study, we further characterized this link and found that Na(+)-NQR affects toxT expression only at the early-log growth phase, whereas lack of Na(+)-NQR decreases CT production after the mid-log growth phase. Such decreased CT production was independent of toxT and ctxB transcription. Supplementing a respiratory substrate, l-lactate, into the growth media restored CT production in the nqrA-F mutant, suggesting that decreased CT production in the Na(+)-NQR mutant is dependent on electron transport chain (ETC) activity. This notion was supported by the observations that two chemical inhibitors, a Na(+)-NQR specific inhibitor 2-n-Heptyl-4-hydroxyquinoline N-oxide (HQNO) and a succinate dehydrogenase (SDH) inhibitor, thenoyltrifluoroacetone (TTFA), strongly inhibited CT production in both classical and El Tor biotype strains of V. cholerae. Accordingly, we propose the main respiratory enzyme of V. cholerae, as a potential drug target to treat cholera because human mitochondria do not contain Na(+)-NQR orthologs.


Assuntos
Proteínas de Bactérias/metabolismo , Toxina da Cólera/biossíntese , Complexo I de Transporte de Elétrons/metabolismo , Regulação Bacteriana da Expressão Gênica , Fatores de Transcrição/metabolismo , Vibrio cholerae O1/metabolismo , Proteínas de Bactérias/genética , Complexo I de Transporte de Elétrons/antagonistas & inibidores , Hidroxiquinolinas/farmacologia , Sódio/metabolismo , Succinato Desidrogenase/antagonistas & inibidores , Succinato Desidrogenase/metabolismo , Tenoiltrifluoracetona/farmacologia , Fatores de Transcrição/genética , Vibrio cholerae O1/efeitos dos fármacos , Vibrio cholerae O1/genética , Fatores de Virulência/genética , Fatores de Virulência/metabolismo
3.
Biol Pharm Bull ; 34(10): 1631-4, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21963508

RESUMO

In our previous study, two synthetic thiophenes such as IMB-05 and IMB-15 were found as peroxisome proliferator-activated receptor gamma (PPARγ) agonists and exhibited beneficial effects on glucose tolerance of diabetic mice in vivo. In the present study, their effect on the transactivity of other nuclear receptors was further investigated. IMB-05 and IMB-15 could not only activated PPARγ but also efficiently activate PPARα in GAL4-hPPARα/γ (ligand binding domain (LBD)) chimeric receptor assay and PPAR response element (PPRE)-luc reporter gene assay with EC(50) values of 1.8-5.2 µM, whereas no activity was observed in other nuclear receptor assays. In addition, the maximal efficacy of IMB-05 and IMB-15 in activating PPARα/γ was approximately 30% of that observed with Wy14643 and rosiglitazone. These data indicate that the two thiophene derivatives are novel class of partial PPARα/γ dual agonists, which may be the mechanism underlying their regulatory effects on glucose homeostasis.


Assuntos
Hipoglicemiantes/farmacologia , PPAR alfa/agonistas , PPAR gama/agonistas , Pirimidinas/farmacologia , Sulfóxidos/farmacologia , Tenoiltrifluoracetona/farmacologia , Tiofenos/farmacologia , Animais , Técnicas de Cultura de Células , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/fisiopatologia , Avaliação Pré-Clínica de Medicamentos , Genes Reporter/efeitos dos fármacos , Hepatócitos , Humanos , Hipoglicemiantes/química , Camundongos , Terapia de Alvo Molecular , PPAR alfa/genética , PPAR gama/genética , Plasmídeos/metabolismo , Receptores Citoplasmáticos e Nucleares/agonistas , Receptores Citoplasmáticos e Nucleares/genética , Rosiglitazona , Sulfóxidos/síntese química , Sulfóxidos/química , Tenoiltrifluoracetona/química , Tiazolidinedionas/farmacologia , Tiofenos/síntese química , Tiofenos/química
4.
Appl Microbiol Biotechnol ; 51(5): 633-8, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10390822

RESUMO

Addition of soybean oil to Acremonium chrysogenum cultures growing on sugars doubled the specific production of cephalosporin C during the idiophase of growth. While the addition of soybean oil had no effect on the total rate of respiration, the respiration that proceeded via the alternative, cyanide-insensitive pathway exhibited a more than twofold increase. Addition of soybean oil also stimulated the formation of isocitrate lyase activities. Inhibition of oxidative metabolism of one of the products of isocitrate lyase (succinate) by thenoyltrifluoroacetone completely inhibited the alternative respiratory pathway. The role of soybean-oil-stimulated alternative respiration in the stimulation of cephalosporin C production and the role of isocitrate lyase are discussed.


Assuntos
Acremonium/metabolismo , Cefalosporinas/metabolismo , Óleo de Soja/metabolismo , Acremonium/efeitos dos fármacos , Acremonium/crescimento & desenvolvimento , Biomassa , Meios de Cultura/química , Fermentação/efeitos dos fármacos , Fermentação/fisiologia , Glucose/metabolismo , Isocitrato Liase/metabolismo , Consumo de Oxigênio/efeitos dos fármacos , Succinato Desidrogenase/antagonistas & inibidores , Ácido Succínico/metabolismo , Tenoiltrifluoracetona/farmacologia , Fatores de Tempo
5.
Biochem J ; 188(1): 31-7, 1980 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-7406888

RESUMO

Rat and pigeon heart mitochondria supplemented with antimycin produce 0.3-1.0nmol of H(2)O(2)/min per mg of protein. These rates are stimulated up to 13-fold by addition of protophores (carbonyl cyanide p-trifluoromethoxyphenylhydrazone, carbonyl cyanide m-chloromethoxyphenylhydrazone and pentachlorophenol). Ionophores, such as valinomycin and gramicidin, and Ca(2+) also markedly stimulated H(2)O(2) production by rat heart mitochondria. The enhancement of H(2)O(2) generation in antimycin-supplemented mitochondria and the increased O(2) uptake of the State 4-to-State 3 transition showed similar protophore, ionophore and Ca(2+) concentration dependencies. Thenoyltrifluoroacetone and N-bromosuccinimide, which inhibit succinate-ubiquinone reductase activity, also decreased mitochondrial H(2)O(2) production. Addition of cyanide to antimycin-supplemented beef heart submitochondrial particles inhibited the generation of O(2) (-), the precursor of mitochondrial H(2)O(2). This effect was parallel to the increase in cytochrome c reduction and it is interpreted as indicating the necessity of cytochrome c(1) (3+) to oxidize ubiquinol to ubisemiquinone, whose autoxidation yields O(2) (-). The effect of protophores, ionophores and Ca(2+) is analysed in relation to the propositions of a cyclic mechanism for the interaction of ubiquinone with succinate dehydrogenase and cytochromes b and c(1) [Wikstrom & Berden (1972) Biochim. Biophys. Acta283, 403-420; Mitchell (1976) J. Theor. Biol.62, 337-367]. A collapse in membrane potential, increasing the rate of ubisemiquinone formation and O(2) (-) production, is proposed as the molecular mechanism for the enhancement of H(2)O(2) formation rates observed on addition of protophores, ionophores and Ca(2+).


Assuntos
Carbonil Cianeto p-Trifluormetoxifenil Hidrazona/farmacologia , Peróxido de Hidrogênio/metabolismo , Ionóforos/farmacologia , Mitocôndrias Cardíacas/metabolismo , Nitrilas/farmacologia , Trifosfato de Adenosina/farmacologia , Animais , Antimicina A/farmacologia , Bromosuccinimida/farmacologia , Cálcio/farmacologia , Columbidae , Técnicas In Vitro , Mitocôndrias Cardíacas/efeitos dos fármacos , Cianeto de Potássio/farmacologia , Ratos , Tenoiltrifluoracetona/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA